Latest filing published 03 Apr 2025 for Verastem, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Matthew Ros: trading record in brief
This profile gathers the share dealings of Matthew Ros across 2 companies, led by Epizyme, Inc. and Verastem, Inc. Between 28 February 2017 and 1 April 2025, the trades on record add up to 27 filings.
The open-market record consists of 11 sales worth €3.2M, with no purchase. Besides market trades, the filings include 12 share grants and 4 option exercises.
The record was last updated on 3 April 2025 with a share grant in Verastem, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Matthew Ros
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares0Common StockSEC:0001104659-25-031706:0
- 28,125 shares0Common Stock, par value $0.0001SEC:0000899243-21-033402:0
2 of 2 declarations
